Skip to content
Study details
Enrolling now

Triamcinolone with Vitamin D Synergistic Efficacy in Psoriasis

Wright State University
NCT IDNCT04036188ClinicalTrials.gov data as of Apr 2026
Phase

EARLY_PHASE1

Target enrollment

24

Study length

about 7.2 years

Ages

18+

Locations

1 site in OH

What this study is about

This trial is testing whether a combination of topical triamcinolone cream and vitamin D3 is more effective than placebo for treating mild to moderate psoriasis. Participants will be treated with triamcinolone cream for four weeks, then randomly assigned to either vitamin D3 or a placebo for an additional twelve weeks. After that, everyone will receive vitamin D3 for another twelve weeks.

Simplified from trial records by PatientMatch.

What you may be asked to do

  • 1.Take Placebo
  • 2.Take Triamcinolone
  • 3.Vitamin D3

Participation Burden

What's physically and logistically required of participants.

Logistics & Travel
In-person visits

Requires travel to a study site

Physical Intervention
Oral

How treatment is administered

Treatment Assignment
Randomized & Blinded

You may get a placebo/standard care, and you won't know which.

Extracted study details

Pulled from the trial record to show what is being tested and what the study is measuring.

Drug classes

triamcinolone

Drug routes

oral (Oral Tablet)

Body systems

Dermatology